[1]马远,彭小荷,郭雄飞,等.纳米羟基磷灰石/聚酰胺66椎间融合器与钛网植骨融合治疗多节段脊髓型颈椎病的对比研究[J].中医正骨,2020,32(10):19-25.
 MA Yuan,PENG Xiaohe,GUO Xiongfei,et al.A comparative study of bone graft fusion with nano-hydroxyapatite/polyamide 66 cage versus titanium mesh cage for treatment of multiple-segment cervical spondylotic myelopathy[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(10):19-25.
点击复制

纳米羟基磷灰石/聚酰胺66椎间融合器与钛网植骨融合治疗多节段脊髓型颈椎病的对比研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第32卷
期数:
2020年10期
页码:
19-25
栏目:
临床研究
出版日期:
2020-10-20

文章信息/Info

Title:
A comparative study of bone graft fusion with nano-hydroxyapatite/polyamide 66 cage versus titanium mesh cage for treatment of multiple-segment cervical spondylotic myelopathy
作者:
马远彭小荷郭雄飞程省宋博王挺叶向阳
(南阳市中心医院,河南 南阳 473003)
Author(s):
MA YuanPENG XiaoheGUO XiongfeiCHENG ShengSONG BoWANG TingYE Xiangyang
Nanyang Central Hospital,Nanyang 473003,Henan,China
关键词:
颈椎病 脊柱融合术 椎间融合器 纳米羟基磷灰石/聚酰胺66 临床试验
Keywords:
cervical spondylosis spinal fusion cage nano-hydroxyapatite/polyamide 66 clinical trial
摘要:
目的:比较纳米羟基磷灰石/聚酰胺66(nano-hydroxyapatite/polyamide 66,n-HA/PA66)椎间融合器与钛网植骨融合治疗多节段脊髓型颈椎病(cervical spondylotic myelopathy,CSM)的临床疗效及安全性。方法:回顾性分析52例接受颈前路椎体次全切减压植骨融合术治疗的多节段CSM患者的病例资料,其中采用n-HA/PA66椎间融合器者24例(n-HA/PA66组)、采用钛网者28例(钛网组)。男30例,女22例。年龄32~72岁,中位数58岁。2节段CSM38例,3节段CSM14例。比较2组患者的手术时间、术中出血量、术后引流量、住院时间、日本骨科学会(Japanese Orthopaedic Association,JOA)脊髓型颈椎病评分(17分法)、颈部疼痛视觉模拟量表(visual analogue scale,VAS)评分、融合节段高度、融合节段Cobb角、植骨融合率、植骨融合物沉降率及并发症发生情况。结果:2组患者手术时间、术中出血量、术后引流量、住院时间比较,组间差异均无统计学意义[(147.60±30.32)min,(150.48±28.77)min,t=0.351,P=0.727;(130.20±42.67)mL,(127.78±45.43)mL,t=0.197,P=0.845;(57.28±10.20)mL,(60.35±12.56)mL,t=0.957,P=0.343;(15.72±4.32)d,(14.38±5.57)d,t=0.957,P=0.343]。术前和末次随访时,2组患者JOA脊髓型颈椎病评分比较,组间差异均无统计学意义[(12.32±1.23)分,(11.62±2.21)分,t=1.378,P=0.174;(15.25±1.81)分,(15.10±1.74)分,t=0.304,P=0.762]; 末次随访时,2组患者JOA脊髓型颈椎病评分均高于术前(t=6.559,P=0.000; t=6.547,P=0.000)。术前和末次随访时,2组患者颈部疼痛VAS评分比较,组间差异均无统计学意义[(4.34±1.53)分,(4.55±1.75)分,t=0.457,P=0.650;(1.31±1.03)分,(1.48±0.98)分,t=0.609,P=0.545]; 末次随访时,2组患者颈部疼痛VAS评分均低于术前(t=8.048,P=0.000; t=8.099,P=0.000)。术前2组患者融合节段高度比较,组间差异无统计学意义[(55.25±10.34)mm,(54.21±7.75)mm,t=0.414,P=0.681]; 末次随访时,n-HA/PA66组的融合节段高度高于钛网组[(63.19±9.23)mm,(58.32±7.20)mm,t=2.201,P=0.032],2组患者的融合节段高度均较术前增加(t=2.806,P=0.007; t=2.056,P=0.045)。术前2组患者融合节段Cobb角比较,组间差异无统计学意义[5.50°±4.07°,5.32°±3.11°,t=0.181,P=0.857]; 末次随访时,n-HA/PA66组的融合节段Cobb角大于钛网组[9.06°±3.28°,7.21°±1.34°,t=2.734,P=0.009],2组患者融合节段Cobb角均较术前增大(t=3.337,P=0.002; t=2.953,P=0.005)。末次随访时,n-HA/PA66组23例植骨融合,钛网组26例植骨融合; 2组患者的植骨融合率比较,差异无统计学意义(χ2=0.019,P=0.890)。末次随访时,n-HA/PA66组2例出现植骨融合物沉降,钛网组9例出现植骨融合物沉降; n-HA/PA66组的植骨融合物沉降率低于钛网组(χ2=4.392,P=0.036)。n-HA/PA66组3例出现C5神经根麻痹,采用非甾体类抗炎镇痛药治疗后症状消失; 2例出现脑脊液漏,经引流及加强换药后治愈; 1例出现吞咽困难,未进行特殊治疗,术后2周症状自然消失。钛网组4例出现C5神经根麻痹、1例出现脑脊液漏、2例出现吞咽困难,处理方法及结果与n-HA/PA66组相同; 1例出现切口浅表感染,经加强换药后治愈。2组患者并发症发生率比较,差异无统计学意义(χ2=0.084,P=0.772)。结论:采用n-HA/PA66椎间融合器与钛网行颈前路椎体次全切减压植骨融合治疗CSM,两者的短期疗效及安全性相当,但前者的融合节段高度、融合节段Cobb角、植骨融合物沉降率均优于后者。
Abstract:
To compare the clinical curative effects and safety of bone graft fusion with nano-hydroxyapatite/polyamide 66(n-HA/PA66)cage versus titanium mesh(TM)cage for treatment of multiple-segment cervical spondylotic myelopathy(CSM).Methods:The medical records of 52 patients who received anterior cervical corpectomy and fusion(ACCF)for treatment of multiple-segment CSM were analyzed retrospectively.Twenty-four patients were treated with n-HA/PA66 cage(n-HA/PA66 group),while the others were treated with TM cage(TM group).The patients consisted of 30 males and 22 females,and ranged in age from 32 to 72 years(Median=58 yrs).The pathological changes located at two segments(38 cases)and three segments(14 cases)respectively.The operative time,intraoperative blood loss,postoperative drainage volume,hospital stay,Japanese Orthopedic Association(JOA)CSM scores,neck pain visual analogue scale(VAS)score,height and Cobb angle of fused segment,bone graft fusion rate,subsidence rate of cage and complications were compared between the 2 groups.Results:There was no statistical difference in operative time,intraoperative blood loss,postoperative drainage volume and hospital stay between the 2 groups(147.60+/-30.32 vs 150.48+/-28.77 min,t=0.351,P=0.727; 130.20+/-42.67 vs 127.78+/-45.43 mL,t=0.197,P=0.845; 57.28+/-10.20 vs 60.35+/-12.56 mL,t=0.957,P=0.343; 15.72+/-4.32 vs 14.38+/-5.57 days,t=0.957,P=0.343).There was no statistical difference in JOA CSM score between the 2 groups before the surgery and at last follow-up(12.32+/-1.23 vs 11.62+/-2.21 points,t=1.378,P=0.174; 15.25+/-1.81 vs 15.10+/-1.74 points,t=0.304,P=0.762).The JOA CSM scores increased in the 2 groups at last follow-up compared to pre-surgery(t=6.559,P=0.000; t=6.547,P=0.000).There was no statistical difference in neck pain VAS score between the 2 groups before the surgery and at last follow-up(4.34+/-1.53 vs 4.55+/-1.75 points,t=0.457,P=0.650; 1.31+/-1.03 vs 1.48+/-0.98 points,t=0.609,P=0.545).The neck pain VAS scores decreased in the 2 groups at last follow-up compared to pre-surgery(t=8.048,P=0.000; t=8.099,P=0.000).There was no statistical difference in the height of fused segment between the 2 groups before the surgery(55.25+/-10.34 vs 54.21+/-7.75 mm,t=0.414,P=0.681).The height of fused segment was higher in n-HA/PA66 group compared to TM group at last follow-up(63.19+/-9.23 vs 58.32+/-7.20 mm,t=2.201,P=0.032),and increased in the 2 groups at last follow-up compared to pre-surgery(t=2.806,P=0.007; t=2.056,P=0.045).There was no statistical difference in the Cobb angle of fused segment between the 2 groups before the surgery(5.50+/-4.07 vs 5.32+/-3.11 degrees,t=0.181,P=0.857).The Cobb angle of fused segment was greater in n-HA/PA66 group compared to TM group at last follow-up(9.06+/-3.28 vs 7.21+/-1.34 degrees,t=2.734,P=0.009),and increased in the 2 groups at last follow-up compared to pre-surgery(t=3.337,P=0.002; t=2.953,P=0.005).At last follow-up,the bone graft fusion was found in 23 patients in n-HA/PA66 group and 26 patients in TM group.There was no statistical difference in bone graft fusion rate between the 2 groups(χ2=0.019,P=0.890).The subsidence of cage was found in 2 patients in n-HA/PA66 group and 9 patients in TM group,and the subsidence rate of cage was lower in n-HA/PA66 group compared to TM group(χ2=4.392,P=0.036).等

参考文献/References:

[1] NOURI A,TETREAULT L,SINGH A,et al.Degenerative cervical myelopathy:epidemiology,genetics,and pathogenesis[J].Spine(Phila Pa 1976),2015,40(12):E675-E693.
[2] MCCORMICK J R,SAMA A J,SCHILLER N C,et al.Cervical spondylotic myelopathy:a guide to diagnosis and management[J].J Am Board Fam Med,2020,33(2):303-313.
[3] 钱晶晶,徐浩,王路,等.颈椎后路单侧椎弓根螺钉内固定术结合单开门椎管扩大成形术治疗合并颈椎不稳的多节段脊髓型颈椎病[J].中医正骨,2019,31(3):42-45.
[4] 何少奇,汤呈宣,唐小君,等.颈后路单开门椎管扩大成形跳跃式与连续式微型钛板内固定术治疗多节段脊髓型颈椎病的对比研究[J].中医正骨,2019,31(4):8-16.
[5] 关晓明,马迅.脊髓型颈椎病手术入路及减压融合方式的选择策略[J].中华骨科杂志,2019,39(23):1478-1484.
[6] YANG X,CHEN Q,LIU L,et al.Comparison of anterior cervical fusion by titanium mesh cage versus nano-hydroxyapatite/polyamide cage following single-level corpectomy[J].Int Orthop,2013,37(12):2421-2427.
[7] 胡鉴瑜,欧云生,朱勇,等.纳米羟基磷灰石/聚酰胺66椎间融合器用于腰椎退变性侧凸椎间融合的疗效[J].中国修复重建外科杂志,2019,33(3):287-295.
[8] 梁欣洁,钟伟洋,权正学,等.纳米羟基磷灰石/聚酰胺66融合器在颈椎前路椎间融合术中应用的中期效果[J].中国脊柱脊髓杂志,2018,28(4):297-302.
[9] 宋海涛,张伟,李民,等.纳米羟基磷灰石/聚酰胺66椎体支撑体在颈椎前路手术重建中的应用[J].中国矫形外科杂志,2018,26(17):1560-1564.
[10] 王文军,薛静波,晏怡果,等.新型解剖型纳米笼架在腰椎前路椎间融合中的应用[J].中国矫形外科杂志,2017,25(19):1735-1740.
[11] 赵玉沛,陈孝平.外科学[M].3版.北京:人民卫生出版社,2015:964-966.
[12] 蒋协远,王大伟.骨科临床疗效评价标准[M].北京:人民卫生出版社,2005:104.
[13] ZHANG Y,DENG X,JIANG D,et al.Long-term results of anterior cervical corpectomy and fusion with nano-hydroxyapatite/polyamide 66 strut for cervical spondylotic myelopathy[J].Sci Rep,2016,6:26751.
[14] 徐用亿,王守国,孙进,等.比较分析三种颈前路减压植骨融合术治疗多节段颈椎病疗效[J].中国矫形外科杂志,2015,23(23):2118-2122.
[15] 李超,葛丰,何勍,等.前路颈椎单椎体次全切除术中采用髂骨块植骨/Cage填充自体碎骨植骨治疗脊髓型颈椎病[J].脊柱外科杂志,2019,17(6):374-378.
[16] 李云鹏,陈晓亮,马进峰,等.应用同种异体植骨融合术治疗脊髓型颈椎病的远期疗效[J].颈腰痛杂志,2013,34(3):205-209.
[17] WEN Z,LU T,WANG Y,et al.Anterior cervical corpectomy and fusion and anterior cervical discectomy and fusion using titanium mesh cages for treatment of degenerative cervical pathologies:a literature review[J].Med Sci Monit,2018,24:6398-6404.
[18] KANG J H,IM S B,YANG S M,et al.Surgical reconstruction using a flanged mesh cage without plating for cervical spondylotic myelopathy and a symptomatic ossified posterior longitudinal ligament[J].J Korean Neurosurg Soc,2019,62(6):671-680.
[19] YAN D,WANG Z,DENG S,et al.Anterior corpectomy and reconstruction with titanium mesh cage and dynamic cervical plate for cervical spondylotic myelopathy in elderly osteoporosis patients[J].Arch Orthop Trauma Surg,2011,131(10):1369-1374.
[20] HU B,YANG X,HU Y,et al.The n-HA/PA66 cage versus the PEEK cage in anterior cervical fusion with single-level discectomy during 7 years of follow-up[J].World Neurosurg,2019,123:e678-e684.
[21] XU Q,LU H,ZHANG J,et al.Tissue engineering scaffold material of porous nanohydroxyapatite/polyamide-66[J].Int J Nanomedicine,2010,5:331-335.
[22] QIAO B,LI J,ZHU Q,et al.Bone plate composed of a ternary nano-hydroxyapatite/polyamide 66/glass fiber composite:biomechanical properties and biocompatibility[J].Int J Nanomedicine,2014,9:1423-1432.
[23] 马金梁,黄帆,汪洋,等.双表达重组腺病毒介导的骨形态发生蛋白2-9复合纳米羟基磷灰石/聚酰胺66融合器用于山羊椎间融合的效果评价[J].吉林大学学报(医学版),2012,38(6):1086-1090.
[24] HU B,WANG L,SONG Y,et al.A comparison of long-term outcomes of nanohydroxyapatite/polyamide-66 cage and titanium mesh cage in anterior cervical corpectomy and fusion:a clinical follow-up study of least 8 years[J].Clin Neurol Neurosurg,2019,176:25-29.

相似文献/References:

[1]孙献武,于香兰,邵海燕,等.应用三维动静态平衡康复模式治疗 非脊髓型颈椎病的临床研究[J].中医正骨,2015,27(11):8.
 SUN Xianwu,YU Xianglan,SHAO Haiyan,et al.Clinical study on three-dimensional dynamic and static equilibrium rehabilitation modality in the treatment of non-myelopathy type cervical spondylosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(10):8.
[2]江建春.神经根型颈椎病的中医药治疗研究概况[J].中医正骨,2015,27(11):71.
[3]韦英成,董彤,吴肖梅,等.推拿手法治疗神经根型颈椎病的研究进展[J].中医正骨,2015,27(10):65.
[4]张莉,秦丹霞,张细姣.Orem自理理论在前路手术治疗脊髓型颈椎病 围手术期护理中的应用[J].中医正骨,2015,27(09):75.
[5]郭小伟,梅伟,潘玉林,等.一期后路病灶清除纳米仿生骨椎体支撑体植骨融合 内固定治疗胸腰椎结核[J].中医正骨,2015,27(07):66.
[6]邸保林,董国顺,林红猛.俯卧斜扳法治疗神经根型颈椎病[J].中医正骨,2015,27(07):70.
[7]白玉,王爱国.郭春园教授治疗颈椎病的学术思想探究[J].中医正骨,2015,27(02):64.
[8]郝庆英,刘楚吟,付婵娟,等.Hybrid手术治疗脊髓型颈椎病的护理[J].中医正骨,2015,27(02):78.
[9]魏社军,王宇,郑标,等.单侧椎弓根螺钉内固定结合椎间融合器植骨融合治疗 相邻双节段腰椎间盘突出症合并腰椎管狭窄[J].中医正骨,2015,27(06):46.
[10]王翔,詹红生,张明才,等.石氏手法治疗神经根型颈椎病的疗效观察[J].中医正骨,2015,27(04):12.
 WANG Xiang,ZHAN Hongsheng,ZHANG Mingcai,et al.Observation on the curative effect of Shi's manipulation in the treatment of cervical spondylotic radiculopathy[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(10):12.
[11]夏炳江,童培建,韦金忠,等.电针夹脊穴治疗脊髓型颈椎病颈前路椎间盘切除减压植骨融合术后残留神经症状[J].中医正骨,2016,28(12):46.
[12]张方舒,梅伟,王金炉,等.椎间融合器原位植骨与自体髂骨植骨治疗脊髓型颈椎病的疗效比较…[J].中医正骨,2017,29(12):38.
 ZHANG Fangshu,MEI Wei,WANG Jinlu,et al.A clinical comparison of bone transplantation with cage in natural position versus autologous iliac bone transplantation for treatment of cervical spondylotic myelopathy[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(10):38.
[13]马潇苒,李无阴,马虎升,等.高速磨钻在颈椎前路减压椎间融合术治疗椎体后缘骨赘型脊髓型颈椎病中的应用[J].中医正骨,2018,30(12):67.
[14]周英杰.颈椎前路融合与非融合手术在脊髓型颈椎病治疗中的合理选择[J].中医正骨,2019,31(08):1.
[15]李永革.零切迹颈前路椎间融合内固定系统治疗脊髓型颈椎病[J].中医正骨,2020,32(03):70.
[16]李亚伟,梅伟,张振辉,等.显微镜辅助下前路颈椎间盘切除融合术治疗骨性压迫致神经根型颈椎病的临床研究[J].中医正骨,2022,34(10):18.
 LI Yawei,MEI Wei,ZHANG Zhenhui,et al.A clinical study of microscope-assisted anterior cervical discectomy and fusion for treatment of cervical spondylotic radiculopathy caused by bone compression[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(10):18.

备注/Memo

备注/Memo:
通讯作者:叶向阳 E-mail:yexyang2008@163.com
更新日期/Last Update: 2020-10-20